Cas:497833-04-2 1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde manufacturer & supplier

We serve Chemical Name:1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde CAS:497833-04-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde

Chemical Name:1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde
CAS.NO:497833-04-2
Synonyms:1H-Pyrazole-4-carboxaldehyde, 1-methyl-5-(trifluoromethyl)-;1-methyl-5-trifluoromethyl-4-pyrazolecarbaldehyde;4-FORMYL-5-(TRIFLUOROMETHYL)-1-METHYL-1H-PYRAZOLE;1-Methyl-5-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde;1-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE
Molecular Formula:C6H5F3N2O
Molecular Weight:178.112
HS Code:2933199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:232.0±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.472
PSA:34.89000
Exact Mass:178.035400
LogP:1.38

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1H-Pyrazole-4-carboxaldehyde, 1-methyl-5-(trifluoromethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole-4-carboxaldehyde, 1-methyl-5-(trifluoromethyl)- Use and application,1H-Pyrazole-4-carboxaldehyde, 1-methyl-5-(trifluoromethyl)- technical grade,usp/ep/jp grade.


Related News: ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde manufacturer Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde supplier Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde vendor ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 1-methyl-5-(trifluoromethyl)pyrazole-4-carbaldehyde factory Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.